How cancer cells avoid shutdown
Researchers unravel mechanisms by which a protein that promotes tumour growth is produced during stress
Breast cancer is the second most common cause of cancer deaths in American women. The most critical step in progression of the tumour is the switch from contained cancer to the seeding of new tumours at distant sites – so called metastases. The process of developing metastases is stressful for cancer cells because big tumours suffer from poor oxygen and nutrient supply. Therefore, many cancer cells shut down the production of new proteins and cannot make it to a metastatic state. However, some cancers find ways to overcome these obstacles and synthesize proteins that promote their further tumour growth and metastasis.
The specific protein concerned in the team’s study is the protease cathepsin L, a certain enzyme. It is long known that high levels of this protease in breast cancers are associated with high metastasis rates and poor survival of the patients. On the other hand, cancer stress conditions prompt tumour cells to down-regulate synthesis of most proteins to save energy, mainly by inhibiting the translation of mRNA into protein. However, the researchers observed that cathepsin L levels are maintained in mouse and human breast cancer tissues and cells even when these were exposed to stress. To address this, the research team analysed the association of various mRNAs to so-called polyribosome complexes. These complexes are made of an mRNA with several protein-synthesizing ribosomes associated to this mRNA. This assembly line ensures efficient synthesis of large quantities of a protein from a single mRNA molecule. The researchers showed that cathepsin L mRNA is constantly associated to polyribosome complexes even under stress conditions. This indicates highly efficient translation of cathepsin L although production of other proteins was shut down. This advantage of cathepsin L mRNA seemed to be dependent on its localization within the cell whereby cathepsin L mRNA might escape from stress granules, which are translationally silent protein and mRNA accumulations formed in stressed cells.
Original publication
Martina Tholen, Julia Wolanski, Britta Stolze, Marco Chiabudini, Mieczyslaw Gajda, Peter Bronsert, Elmar Stickeler, Sabine Rospert, and Thomas Reinheckel (2015). Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression. Journal of Biological Chemistry 290.25.
Original publication
Martina Tholen, Julia Wolanski, Britta Stolze, Marco Chiabudini, Mieczyslaw Gajda, Peter Bronsert, Elmar Stickeler, Sabine Rospert, and Thomas Reinheckel (2015). Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression. Journal of Biological Chemistry 290.25.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.